Ultragenyx Pharmaceutical, Inc. (RARE)
16.07
-0.20
(-1.23%)
USD |
NASDAQ |
Nov 13, 16:00
16.07
0.00 (0.00%)
After-Hours: 19:59
Ultragenyx Pharmaceutical Market Cap : 1.638B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.658B |
| November 11, 2026 | 1.702B |
| November 10, 2026 | 1.645B |
| November 09, 2026 | 1.672B |
| November 06, 2026 | 1.572B |
| November 05, 2026 | 1.587B |
| November 04, 2026 | 1.749B |
| November 03, 2026 | 1.695B |
| November 02, 2026 | 1.661B |
| October 30, 2026 | 1.583B |
| October 29, 2026 | 1.649B |
| October 28, 2026 | 1.691B |
| October 27, 2026 | 1.647B |
| October 26, 2026 | 1.581B |
| October 23, 2026 | 1.538B |
| October 22, 2026 | 1.568B |
| October 21, 2026 | 1.565B |
| October 20, 2026 | 1.575B |
| October 19, 2026 | 1.481B |
| October 16, 2026 | 1.429B |
| October 15, 2026 | 1.491B |
| October 14, 2026 | 1.465B |
| October 13, 2026 | 1.467B |
| October 12, 2026 | 1.504B |
| October 09, 2026 | 1.522B |
| Date | Value |
|---|---|
| October 08, 2026 | 1.503B |
| October 07, 2026 | 1.464B |
| October 06, 2026 | 1.421B |
| October 05, 2026 | 1.425B |
| October 02, 2026 | 1.496B |
| October 01, 2026 | 1.450B |
| September 30, 2026 | 1.477B |
| September 29, 2026 | 1.506B |
| September 28, 2026 | 1.417B |
| September 25, 2026 | 1.425B |
| September 24, 2026 | 1.452B |
| September 23, 2026 | 1.463B |
| September 22, 2026 | 1.535B |
| September 21, 2026 | 1.440B |
| September 18, 2026 | 1.426B |
| September 17, 2026 | 1.425B |
| September 16, 2026 | 1.266B |
| September 15, 2026 | 1.285B |
| September 14, 2026 | 1.338B |
| September 11, 2026 | 1.406B |
| September 10, 2026 | 1.416B |
| September 09, 2026 | 1.407B |
| September 08, 2026 | 1.463B |
| September 04, 2026 | 1.504B |
| September 03, 2026 | 1.460B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 4.833B |
| AbbVie, Inc. | 521.43B |
| Krystal Biotech, Inc. | 9.043B |
| BridgeBio Pharma, Inc. | 15.35B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
Market Cap Related Metrics
| PS Ratio | 2.226 |
| Price | 16.07 |
| Earnings Yield | -32.29% |